...
机译:Src抑制剂对获得性MET扩增的吉非替尼耐药非小细胞肺癌细胞生长及表皮生长因子受体和MET信号的影响
Department of Medical Oncology, Kinki University School of Medicine, Osaka-Sayama, Osaka;
Department of Medical Oncology, Kinki University School of Medicine, Osaka-Sayama, Osaka;
Department of Medical Oncology, Kinki University School of Medicine, Osaka-Sayama, Osaka;
Department of Medical Oncology, Kinki University School of Medicine, Osaka-Sayama, Osaka;
Department of Medical Oncology, Kinki University School of Medicine, Osaka-Sayama, Osaka;
Department of Medical Oncology, Kinki University School of Medicine, Osaka-Sayama, Osaka;
Department of Genome Biology, Kinki University School of Medicine, Osaka-Sayama, Osaka;
Department of Medical Oncology, Kinki University School of Medicine, Sakai Hospital, Minami-ku Sakai, Osaka, Japan;
Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston|Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA;
Department;
机译:Src抑制剂对获得性MET扩增的吉非替尼耐药非小细胞肺癌细胞生长及表皮生长因子受体和MET信号的影响。
机译:Src抑制剂对获得性 MET I>扩增的吉非替尼耐药非小细胞肺癌细胞生长及表皮生长因子受体和MET信号的影响
机译:在表皮生长因子受体抑制剂吉非替尼中添加S-1可通过MET扩增克服非小细胞肺癌细胞系中的吉非替尼耐药性。
机译:氢气/氘交换质谱法测量的表皮生长因子受体细胞外结构域的影响
机译:酪氨酸激酶抑制剂对表皮生长因子受体突变的非小细胞肺癌中维生素D受体表达和基因调控的意外影响。
机译:表皮生长因子受体突变体非小细胞肺癌和脉络膜转移:长期结果和对表皮生长因子受体酪氨酸激酶抑制剂的反应
机译:SRC抑制剂对细胞生长和表皮生长因子受体的影响,并获得达到达达型扩增吉替尼抗性非小细胞肺癌细胞信号传导